These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11446532)

  • 1. Inhibition of hyphal growth of Candida albicans by activated lansoprazole, a novel benzimidazole proton pump inhibitor.
    Biswas SK; Yokoyama K; Kamei K; Nishimura K; Miyaji M
    Med Mycol; 2001 Jun; 39(3):283-5. PubMed ID: 11446532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Suppressive effect of lansoprazole on anti-Candida activity of murine macrophages].
    Motegi H; Abe S; Tansho S; Suzuki D; Yamaguchi H; Hoshino E
    Kansenshogaku Zasshi; 2001 Feb; 75(2):137-43. PubMed ID: 11260880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori urease inhibition by rabeprazole, a proton pump inhibitor.
    Tsuchiya M; Imamura L; Park JB; Kobashi K
    Biol Pharm Bull; 1995 Aug; 18(8):1053-6. PubMed ID: 8535394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth inhibition of Ureaplasma urealyticum by the proton pump inhibitor lansoprazole: direct attribution to inhibition by lansoprazole of urease activity and urea-induced ATP synthesis in U. urealyticum.
    Nagata K; Takagi E; Satoh H; Okamura H; Tamura T
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2187-92. PubMed ID: 8619564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori.
    Iwahi T; Satoh H; Nakao M; Iwasaki T; Yamazaki T; Kubo K; Tamura T; Imada A
    Antimicrob Agents Chemother; 1991 Mar; 35(3):490-6. PubMed ID: 2039199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific proton pump inhibitors E3810 and lansoprazole affect the recovery process of gastric secretion in rats differently.
    Tomiyama Y; Morii M; Takeguchi N
    Biochem Pharmacol; 1994 Nov; 48(11):2049-55. PubMed ID: 7802694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of proton pump inhibitors on thyroid hormone metabolism in rats: a comparison of UDP-glucuronyltransferase induction.
    Masubuchi N; Hakusui H; Okazaki O
    Biochem Pharmacol; 1997 Dec; 54(11):1225-31. PubMed ID: 9416973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory action of lansoprazole and its analogs against Helicobacter pylori: inhibition of growth is not related to inhibition of urease.
    Nagata K; Takagi E; Tsuda M; Nakazawa T; Satoh H; Nakao M; Okamura H; Tamura T
    Antimicrob Agents Chemother; 1995 Feb; 39(2):567-70. PubMed ID: 7726537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism of Fluconazole and a Proton Pump Inhibitor against Candida albicans.
    Liu NN; Köhler JR
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1145-7. PubMed ID: 26596946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Discovery and development of the proton pump inhibitor].
    Igata H; Okabe S
    Nihon Rinsho; 1992 Jan; 50(1):11-7. PubMed ID: 1311779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and effect on caffeine metabolism of the proton pump inhibitors, omeprazole, lansoprazole, and pantoprazole.
    Andersson T; Holmberg J; Röhss K; Walan A
    Br J Clin Pharmacol; 1998 Apr; 45(4):369-75. PubMed ID: 9578184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.
    Andersson T
    Clin Pharmacokinet; 1996 Jul; 31(1):9-28. PubMed ID: 8827397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial actions of benzimidazoles against oral streptococci.
    Nguyen PT; Baldeck JD; Olsson J; Marquis RE
    Oral Microbiol Immunol; 2005 Apr; 20(2):93-100. PubMed ID: 15720569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The yeast plasma membrane proton pumping ATPase is a viable antifungal target. I. Effects of the cysteine-modifying reagent omeprazole.
    Monk BC; Mason AB; Abramochkin G; Haber JE; Seto-Young D; Perlin DS
    Biochim Biophys Acta; 1995 Oct; 1239(1):81-90. PubMed ID: 7548148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gastric H,K-ATPase blocker lansoprazole is an inhibitor of chloride channels.
    Schmarda A; Dinkhauser P; Gschwentner M; Ritter M; Fürst J; Scandella E; Wöll E; Laich A; Rossmann H; Seidler U; Lang F; Paulmichl M
    Br J Pharmacol; 2000 Feb; 129(3):598-604. PubMed ID: 10711360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of potential digoxin-rabeprazole interaction after formulary conversion of proton-pump inhibitors.
    Le GH; Schaefer MG; Plowman BK; Morreale AP; Delattre M; Okino L; Felicio L
    Am J Health Syst Pharm; 2003 Jul; 60(13):1343-5. PubMed ID: 12901036
    [No Abstract]   [Full Text] [Related]  

  • 17. [Submicroscopic aspects of the mechanism of inhibitors of H+/K+-ATPase in gastric parietal cells].
    Morozov IA
    Eksp Klin Gastroenterol; 2002; (3):94-100, 122. PubMed ID: 12353402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of 24-hour intragastric pH using four liquid formulations of lansoprazole and omeprazole.
    Sharma VK
    Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S18-21. PubMed ID: 10597120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inductions of germ tube and hyphal formations are controlled by mRNA synthesis inhibitor in Candida albicans.
    Imanishi Y; Yokoyama K; Nishimura K
    Nihon Ishinkin Gakkai Zasshi; 2004; 45(2):113-9. PubMed ID: 15118669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rabeprazole: the role of proton pump inhibitors in Helicobacter pylori eradication.
    Sharara AI
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):863-70. PubMed ID: 16307499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.